You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 71 High scoring precision demonstrated in multiple tumor indications stained with PD-L1 IHC 22C3 pharmDx used in conjunction with combined positive score

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
71 High scoring precision demonstrated in multiple tumor indications stained with PD-L1 IHC 22C3 pharmDx used in conjunction with combined positive score
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hand J, Ponce F, Hund S, et al
71 High scoring precision demonstrated in multiple tumor indications stained with PD-L1 IHC 22C3 pharmDx used in conjunction with combined positive score
Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0071